ClinicalTrials.Veeva

Menu

The Preventive Value of Acupoint Sensitization Based on Stable Angina Pectoris

S

Sichuan University

Status

Completed

Conditions

The Clinical Value of Acupoint Sensitization

Treatments

Procedure: Hyposensitive acupoint group
Procedure: Hypersensitive acupoint group

Study type

Interventional

Funder types

Other

Identifiers

NCT03975140
81590955

Details and patient eligibility

About

This study, taking stable angina pectoris as a research carrier, aims to explore the preventive value of acupoint sensitization by conducting a double-blind multi-center randomized controlled trial to compare the effect of stimulating acupoints with different sensitivity on the prevention of angina pectoris.

After the inclusion of eligible patients, the pressure-pain threshold of disease-related acupoints will be detected by using Von Frey detector. Then, the patients will be randomly divided into experimental group and control group. The patients in experimental group will be given acupoints pressure on the five acupoints with the lowest pressure-pain threshold, while the patients in control group will be given acupoints pressure on the five acupoints with the five acupoints with the highest pressure-pain threshold. The two groups will be treated with acupoints pressure 12 times within 4 weeks. The patients will be evaluated three times at baseline, the end of treatment and four weeks after the end of treatment respectively, including angina attack frequency, CCS classification and SAQ score.

Enrollment

202 patients

Sex

All

Ages

35 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with stable angina pectoris and symptoms of chest pain
  • The duration of onset was more than 3 months, and the number of angina attacks in the past month was not less than 2
  • Not younger than 35 years old and not older than 80 years old
  • Patients will participate in the study voluntarily and have signed the informed consent

Exclusion criteria

  • Patients with mental retardation
  • Patients were contraindicated or unable to complete acupoint sensitization test
  • Patients with cardiovascular, digestive, urinary, respiratory, blood, nervous, endocrine system and other serious primary diseases
  • Patients with bleeding, allergy constitution
  • Patients with abnormal skin or peripheral nerve sensation, abnormal pain sensation, skin ulceration at the sensitization detection site
  • Patients with unsatisfactory clinical treatment of hypertension and diabetes

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

202 participants in 2 patient groups

Hypersensitive acupoint group
Experimental group
Treatment:
Procedure: Hypersensitive acupoint group
Hyposensitive acupoint group
Active Comparator group
Treatment:
Procedure: Hyposensitive acupoint group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems